Evidence map›Paper›PMID 36911658›Full record

ArticleJournal of virus eradication2023

Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA.

N Archin, K J Bar, T Burdo, M Caskey, A Chahroudi, M Farzan, Y-C Ho, R B Jones, Mary Kearney, D Kuritzkes and 5 more

Abstract read
In one paragraph

Article in Journal of virus eradication, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

N ArchinDivision of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, USA.
K J BarDept of Medicine, University of Pennsylvania, Philadelphia, USA.
T BurdoDepartment of Microbiology, Immunology and Inflammation, Center for Neurovirology and Gene Editing, Temple University, Philadelphia, USA.
M CaskeyRockefeller University, New York, USA.
A ChahroudiEmory University, School of Medicine, Atlanta, USA.
M FarzanDepartment of Immunology and Microbiology, UF Scripps Biomedical Research, Jupiter, USA.
Y-C HoHIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG), New Haven, USA.
R B JonesDept of Medicine, Weill Cornell Medicine, New York, USA.
Mary KearneyHIV Dynamics and Replication Program, Host-Virus Interaction Branch, National Cancer Institute, National Institutes of Health, Frederick, USA.
D KuritzkesHarvard Medical School Infectious Disease, Boston, USA.
D MargolisUNC Chapel Hill, Chapel Hill, USA.
J Martinez-PicadoIrsiCaixa Institute for AIDS Research, Badalona, Spain.
A OkoyeOregon Health and Science University, USA.
M SalgadoIrsiCaixa Institute for AIDS Research, Badalona, Spain.
Mario StevensonUniversity of Miami Leonard School of Medicine, Miami, USA.

Funding

Dynamics and Genetics of HIV Proviruses Before and During Antiretroviral TherapyZIABC011681 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2025
$9.3M
Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and EvolutionZIABC011699 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2024
$7.1M
Effects of Antiretroviral Therapy on Transcriptional Activity of HIV ProvirusesZIABC011697 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2024
$6.4M
Quantify the Fraction of Proviruses That Express HIV RNA to Better Understand Proviral Latency and Its ReversalZIABC011698 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2025
$5.1M
6 · The paper itself

Abstract

The International Workshop on HIV Persistence during Therapy provides a forum in which HIV/AIDS researchers gather to share the latest research findings related to viral reservoirs and cure. The Tenth Workshop, which was attended by over 400 delegates, extended over 4 days and comprised eight sessions covering topics from the basic science of viral persistence to therapeutic approaches to HIV cure. Furthermore, satellite sessions on the first day of the Conference featuring cure research endeavours being pursued by the Bill and Melinda Gates Foundation as well as those being coordinated under the National Institutes of Health Martin Delaney Collaboratory program, provided important updates on research advances being made in these initiatives. As with previous conferences, the International Workshop on HIV Persistence during Therapy is primarily abstract-driven with only one invited talk for each of the sessions. This format, therefore, increases the number of presentations from early-stage investigators. Furthermore, presentations by Community representatives illustrated approaches to creating cure research literacy with effective messaging for the Community. The following article offers a synopsis of the meeting sessions. Due to space constraints, some presentations may have only been briefly discussed. Nevertheless, the Workshop abstracts can be found online (https://www/sciencedirect.com/journal/journal-of-virus-eradication/vol/8/suppl/S).

Indexed as

HIV cureHIV eradicationHIV functional CureHIV persistenceHIV reservoirs

Identifiers

PMID36911658
PMCPMC9996320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.